Hva betyr "Tøm"?
Dyret bærer ikke mutasjonen. Det vil ikke utvikle sykdommen og vil ikke gi det videre.
Hund Kardiomyopati med ungdomsdødelighet (CJM)
The Cardiomyopathy With Juvenile Mortality (CJM) DNA test in dogs is essential for early detection of this hereditary heart condition. CJM causes severe heart muscle disease leading to sudden death in young dogs, making genetic screening crucial for breeders and pet owners. By identifying carriers and affected dogs, the CJM DNA test helps prevent the spread of this fatal disorder within breeding lines. Early diagnosis through this test allows for better management and care of at-risk dogs. Reliable and accurate, the CJM DNA test supports responsible breeding practices and promotes healthier canine populations. Ensure your dog’s health and future by opting for the Cardiomyopathy With Juvenile Mortality DNA test today. Protect your pet with advanced genetic testing designed to save lives.
Forkortelse: CJM
Analysert mutasjon: YARS2 c.1054G>A
Arv: Autosomal recessiv
Akronym
CJM
Observert frekvens
Klinisk alvorlighetsgrad
Klinisk klassifisering
Kardiovaskulære sykdommer
Analysert mutasjon
YARS2 c.1054G>A
p.(E352K)
p.(E352K)
Metode for arv
Autosomal recessiv (Fullstendig)
Testsammendrag:
The DNA test for Cardiomyopathy With Juvenile Mortality (CJM) in dogs helps identify carriers of this genetic condition. CJM is a serious heart disease that can cause sudden death in young dogs. Early detection through testing allows breeders to make informed decisions and reduce the risk of passing the mutation to offspring. This test is especially important for breeds known to be affected by CJM. Responsible breeding based on DNA results promotes healthier future generations of dogs.
Tilgjengelig fra pakken: Basic
Denne DNA-testen er inkludert fra pakken vår Basic — og er også en del av pakkene Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Velg pakken som passer best til din avl eller helsestrategi for dyrene dine.
Understanding Cardiomyopathy With Juvenile Mortality (CJM) in Dogs
Cardiomyopathy With Juvenile Mortality (CJM) is a serious and often fatal heart condition that primarily affects young dogs. It is characterized by the degeneration of heart muscle, leading to impaired heart function and, in severe cases, sudden cardiac death. CJM typically presents in dogs under the age of two, making early detection and intervention crucial for improving outcomes.
Pathophysiology of CJM
The underlying cause of CJM involves genetic mutations that disrupt the normal structure and function of cardiac muscle cells. As the disease progresses, the heart becomes progressively weaker, resulting in decreased cardiac output and potential rhythm disturbances. These changes can lead to symptoms such as lethargy, weakness, and exercise intolerance, which may rapidly escalate to life-threatening conditions.
Clinical Signs and Diagnosis
Dogs affected by CJM may exhibit a range of clinical signs, including coughing, difficulty breathing, and fainting episodes. Due to the rapid progression of the disease, it is essential for pet owners to seek veterinary attention promptly if they notice any concerning symptoms. Diagnosis typically involves a combination of physical examinations, echocardiography, and electrocardiograms to assess heart function and identify abnormalities.
Administrasjons- og behandlingsalternativer
While there is currently no cure for CJM, management strategies aim to improve the quality of life and prolong survival for affected dogs. Treatment may include medications to support heart function, reduce fluid buildup, and manage arrhythmias. Additionally, lifestyle modifications, such as restricted exercise and regular veterinary check-ups, play an important role in managing the condition effectively.
Viktigheten av genetisk testing
Genetic testing for CJM is a valuable tool for identifying at-risk dogs and guiding breeding decisions. By understanding the genetic predisposition to this condition, breeders can make informed choices to reduce the incidence of CJM in future generations. Furthermore, early identification of affected individuals allows for timely intervention and better management of the disease.
Konklusjon
Cardiomyopathy With Juvenile Mortality (CJM) represents a significant health concern in young dogs, emphasizing the importance of awareness, early detection, and genetic testing. By recognizing the signs of this condition and seeking appropriate veterinary care, pet owners can help ensure their dog's health and well-being. Ongoing research and advancements in genetic testing continue to provide hope for better management and prevention strategies for CJM.
Rase anerkjent for testen: Kardiomyopati med ungdomsdødelighet (CJM)
- Belgian Malinois
- Belgian Sheepdog
- Belgian Shepherd Dog
- Lakenois
🧬 Interpretation of genotypes CJM
Genotype
Status
🟡 N/N
Ikke-transportør - Ingen risiko
🟡 N/CJM
Transportør - Ingen risiko
❌ CJM/CJM
Berørt - i faresonen
FAQ: forstå tolkningen
Er en "Carrier" seriøs?
Nei. Dyret er generelt sunt, men kan overføre mutasjonen til dens avkom.
Hva om et dyr er "påvirket"?
Den har to muterte kopier. Kliniske tegn forventes avhengig av sykdommen. Det skal ikke avles.
Hvorfor er det forskjeller mellom mann og kvinne?
Noen sykdommer er kjønnsbundne, så uttrykket deres varierer avhengig av dyrs kjønn.
Forutsi avkom
N/N (ikke-transportor)
N/CJM (Transportør)
CJM/CJM (Berørt)
Vanlige spørsmål om DNA-test
Hva oppdager denne DNA-testen?
This DNA test detects the mutation associated with Cardiomyopathy With Juvenile Mortality (CJM) in order to identify clear, carrier, or at-risk animals.
Hvorfor teste et avlsdyr?
DNA-testing hjelper oppdrettere med å planlegge sikrere parringer og redusere risikoen for å overføre mutasjonen til avkom.
Hva er arvemodusen for denne testen?
Arvemodusen som er rapportert for denne testen er autosomal recessiv.
Hvilken mutasjon analyseres i denne testen?
This test analyses the mutation YARS2 c.1054G>A.
Er et bærerdyr nødvendigvis påvirket?
Ikke nødvendigvis. Tolkning avhenger av arvemønsteret og den resulterende genotypen.
Referanser
Gurtner Corinne, Hug Petra, Kleiter Miriam, Köhler Kernt, Dietschi Elisabeth, Jagannathan Vidhya, Leeb Tosso. YARS2 Missense Variant in Belgian Shepherd Dogs with Cardiomyopathy and Juvenile Mortality. Genes (Basel). 2020 Mar 14;11(3):313. doi: 10.3390/genes11030313.